Omeros: Novo Nordisk's Licensing Deal Sends Shares Soaring, Makes Bull Case

Group 1 - Omeros Corporation's shares increased by over 150%, reaching $10.40 per share, marking their highest value since January [1] - The investing group Haggerston BioHealth provides insights into biotech, pharma, and healthcare sectors, including sales forecasts and financial analyses [2] Group 2 - The group caters to both novice and experienced investors, offering buy and sell ratings along with market analysis [2]